https://commonstockwarrants.com

After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more…) – StreetInsider.com

After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more…) StreetInsider.com Today’s After-Hours Movers. InspireMD, Inc. (NYSE American: NSPR) 28.6% LOWER; intends to offer and sell shares of its common stock in an underwritten … … Continue reading

After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more…) – StreetInsider.com Read More »

Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock – Nasdaq

Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock Nasdaq HAIFA, Israel, April 03, 2019– Pluristem Therapeutics Inc., a leading regenerative medicine company developing novel placenta-based cell therapy. … Continue reading

Pluristem Therapeutics Inc. Announces Proposed Public Offering of Common Stock and Warrants and Concurrent Registered Direct Offering of Common Stock – Nasdaq Read More »

Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive

Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Entry into a Material Definitive Agreement Item 1.01. Entry into a Material Definitive Agreement. … Continue reading

Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive Read More »

AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive

AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement Item 1.01. Entry into a Material Definitive Agreement. … Continue reading

AZURRX BIOPHARMA, INC. (NASDAQ:AZRX) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive Read More »

AVEO Pharmaceuticals, Inc. Announces Proposed Public Offering – Business Wire

AVEO Pharmaceuticals, Inc. Announces Proposed Public Offering Business Wire AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) (“AVEO” or the “Company”), a biopharmaceutical company seeking to advance targeted medicines for oncology … … Continue reading

AVEO Pharmaceuticals, Inc. Announces Proposed Public Offering – Business Wire Read More »

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units – GlobeNewswire

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units GlobeNewswire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/. SAN FRANCISCO and TEL AVIV, Israel, April 03, 2019 … … Continue reading

Kalytera Therapeutics Announces Short Form Prospectus Offering of Units – GlobeNewswire Read More »